HealthCap Investor Seminar


Event Details


HealthCap, a leading life science venture capital firm, has opened an office in Oslo Cancer Cluster Incubator and also become a member of the Oslo Cancer Cluster. In this relation, HealthCap will host a seminar at the Oslo Cancer Cluster Innovation Park on December 9th at 12.15.

 

Program:

Moderator of the day: Johan Christenson, Partner HealthCap

12:15 Coffee and registration

12:30 Introduction and welcome
Johan Christenson, Partner HealthCap

12:35 Oslo Cancer Cluster: A leading innovation cluster
Ketil Widerberg, CEO

12:40 Innovation in Norway
Mona Skaret, Director Innovation Norway

12:45 HealthCap: Venture capital for Breakthrough therapies
Björn Odlander, Managing Partner

13:05 Targovax: Arming the patient´s immune system to fight cancer
Gunnar Gårdemyr, CEO

13:20 Algeta: Case study Oslo Cancer Cluster biotech and HealthCap
Andrew Kay, former CEO

13:40 Nordic Nanovector: An emerging leader in cancer care
Jan A. Alfheim, COO

 

About HealthCap:
HealthCap invests in companies developing targeted therapies for rare diseases, cancer and genetic diseases, among others. HealthCap was the lead investor in the Norwegian oncology company Algeta, which was acquired by Bayer for USD 2.9 bn, and is the largest shareholder in the Norwegian oncology companies Nordic Nanovector AS and Targovax AS.

 

Print This Post